nalbuphine (PHN-131) / PhytoHealth Corp - LARVOL DELTA

Study of PHN131 in Healthy Volunteers (clinicaltrials.gov) - P=N/A | N=16 | Completed | Sponsor: PhytoHealth Corporation | Terminated ➔ Completed

Trial completion

Safety and Efficacy of Oral Nalbuphine on Postoperative Pain in Hemorrhoidectomy Patients: A Randomized, Double-blind, Placebo-controlled, Pivotal Trial. (PubMed, Clin J Pain) - "Our findings demonstrate that PHN131 is effective and well-tolerated in the treatment of moderate-to-severe post hemorrhoidectomy pain and may provide another option for patients to control their pain."

Clinical • Journal • Addiction (Opioid and Alcohol) • CNS Disorders • Depression • Gastroenterology • Pain • Psychiatry

A Single Bolus of Dexmedetomidine Versus Nalbuphine in Postoperative Agitation (clinicaltrials.gov) - P3 | N=90 | Recruiting | Sponsor: Assiut University | Trial completion date: Dec 2021 ➔ Dec 2023 | Trial primary completion date: Dec 2021 ➔ Oct 2023

Trial completion date • Trial primary completion date

Study of PHN131 in Patients After Surgery (clinicaltrials.gov) - P2/3; N=106; Completed; Sponsor: PhytoHealth Corporation; Active, not recruiting ➔ Completed; Trial completion date: Feb 2016 ➔ Feb 2019

Clinical • Trial completion • Trial completion date